Journal of the Pancreas is known for its integrity and quality among all open-access journals in pancreatic cancer. The journal publishes high quality articles, editorials as well as review articles covering major aspects of Pancreatic Cancer.
Pancreatic cancer is a malignant neoplasm originating from transformed cells arising in tissues forming the pancreas. Pancreatic cancer (cancer of the pancreas) mainly occurs in people aged over 60. If it is diagnosed at an early stage, then an operation to remove the cancer gives some chance of a cure. In general, the more advanced the cancer (the more it has grown and spread), the less chance that treatment will be curative. Both the exocrine and endocrine cells of the pancreas can form tumors. But tumors formed by the exocrine cells are much more common. When someone says that they have pancreatic cancer, they usually mean an exocrine pancreatic cancer. Not all of the tumors in the pancreas are cancer. A small number are not cancer (they are benign). Pancreatic cancer cells do not experience programmatic death, but instead continue to grow and divide.
Journal of the Pancreas is published by OMICS Group, one of the leading Open Access publishers. OMICS International with the noble initiative of Open Access journals has been successful in managing more than 700+ peer-reviewed journals and organizing around 3000+ International Scientific Conferences around the globe annually. These open access journals are strongly supported by efficient editorial board members and other expertise that play a vital role in review process through which qualitative articles get published.
Last date updated on June, 2014